boldenone undecylenate

Equipoise, also known as Boldenone Undecylenate or EQ, is a veterinarian steroid developed by CIBA, to be a form of long-acting injectable dianabol. The intended use was in the horse and cattle industry. In general, EQ comes in an oil suspension that can be injected into animals every 6 weeks. There are no legitimate version of boldenone undecylenate approved by any government anywhere in the world for human use. All of the Equipoise on the market is either from approved veterinarian labs or made in an underground laboratories meant for the black market. Even though it is meant as veterinarian steroid, boldenone is quite powerful when used by humans.

The side effects associated with Equipoise® are generally mild. The structure of boldenone does allow it to convert into estrogen, but it does not have an extremely high affinity to do so. To try and quantify this we can look toward aromatization studies, which suggest that its rate of estrogen conversion should be roughly half that of testosterone’s. The tendency to develop a noticeable amount of water retention with this drug would therefore be slightly higher than that with Deca-DurabolinO (with an estimated 20°/a conversion), but much less than what would be expected with a stronger agent such as Testosterone. While one does still have a chance of encountering an estrogen related side effect as such when using this substance, it is not a common problem when taken at a moderate dosage level. Gynecomastia might theoretically become a concern, but is usually only heaved of with very sensitive individuals or (again) those venturing high in dosage. Should estrogenic effects become troublesome, the addition of Nolvadex® and/or Proviron® should of course make the cycle more tolerable. An antiaromatase such as Cytadren® or Arimidex® would be stronger options, however probably not indicated with a mild drug as such.

Equipoise (Boldenone Undecylenate) is a structurally altered form of testosterone. It is a very slight change in an added double bond at the carbon one and two position. This double bond greatly reduces the hormone’s androgenicity, as well as estrogenic nature. It is then attached to the very large or long Undecylenate ester, which is responsible for controlling the release of the hormone once administered into the body. The Undecylenate ester allows for a peak release in Boldenone approximately 3-4 days after injection, with a slow continuous release of the hormone to follow for approximately 21 days.

Buy Boldenone Undecylenate from reputable store

Showing all 11 results